loading...| Preferred Name |
Silymarin |
|
| Synonyms |
|
|
| Definitions |
A mixture of flavonolignans isolated from the milk thistle plant Silybum marianum. Silymarin may act as an antioxidant, protecting hepatic cells from chemotherapy-related free radical damage. This agent may also promote the growth of new hepatic cells. (NCI04) |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C26671 |
|
| Accepted_Therapeutic_Use_For |
Nutritional supplement for liver damage induced by chemicals or toxins |
|
| ALT_DEFINITION |
A substance obtained from milk thistle seeds that is being studied in the prevention of liver damage caused by certain cancer treatments. |
|
| CAS_Registry |
65666-07-1 |
|
| code |
C26671 |
|
| definition |
A mixture of flavonolignans isolated from the milk thistle plant Silybum marianum. Silymarin may act as an antioxidant, protecting hepatic cells from chemotherapy-related free radical damage. This agent may also promote the growth of new hepatic cells. (NCI04) |
|
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C173383 |
|
| label |
Silymarin |
|
| Legacy Concept Name |
Silymarin |
|
| NCI_Drug_Dictionary_ID |
284684 |
|
| PDQ_Closed_Trial_Search_ID |
284684 |
|
| PDQ_Open_Trial_Search_ID |
284684 |
|
| Preferred_Name |
Silymarin |
|
| prefixIRI |
NCIT:C26671 |
|
| prefLabel |
Silymarin |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0037135 |
|
| subClassOf |